Consortio

Nightstar Therapeutics PLC is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapies for various diseases, including Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Postpartum Depression, Lupus, Multiple Sclerosis, Spinal Muscular Atrophy, and Friedreich Ataxia. With a strong focus on science and innovation, Nightstar Therapeutics is dedicated to transforming patient lives and solving societal problems through transformative medicines. Driven by a deep sense of care and a desire to make a difference, Nightstar Therapeutics pioneers groundbreaking research and clinical trials, aiming to provide access to health equity and promote diversity, equity, and inclusion. With a dedicated team of experts and a robust pipeline of potential treatments, Nightstar Therapeutics is committed to changing lives and creating new possibilities in the field of biotechnology.Generated from the website